Kadilee Adams
Internal Medicine · Temple, TXNPI 1073140612
Payments from drug & device makers
Across 70 payments — averaging $47.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$611
- Medtronic$493
- E.r. Squibb & Sons, L.L.C.$472
- Novartis$393
- Abiomed$254
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$239
- plus $854 from 14 others
What the payments were for
- Food & beverage$3,18196%
- Education$1364%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 12 | $611 |
| Medtronic | 6 | $493 |
| E.r. Squibb & Sons, L.L.C. | 5 | $472 |
| Novartis | 13 | $393 |
| Abiomed | 8 | $254 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $239 |
| Bayer | 2 | $137 |
| AbbVie | 1 | $125 |
| Novo Nordisk | 1 | $124 |
| United Therapeutics Corporation | 1 | $105 |
| Boehringer Ingelheim | 2 | $101 |
| Angiodynamics, Inc. | 2 | $58 |
| Teleflex LLC | 3 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $27 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| AstraZeneca | 1 | $23 |
| Johnson & Johnson | 1 | $22 |
| Bioxcel Therapeutics, Inc. | 1 | $22 |
| Cardiva Medical, Inc. | 1 | $20 |
| Fisher & Paykel Healthcare Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYMPLICITY G3$311
- ELIQUIS$239
- CAMZYOS$213
- CARDIOMEMS$154
- DRAGONFLY OPSTAR$142
- ENSITE$136
- COREVALVE EVOLUT R$135
- EMBLAVEO$125
- Wegovy$124
- Kerendia$123
- LEQVIO$116
- TYVASO$105
How this compares
$3,316 in reported general payments places this provider in the 80th percentile of 7,675 internal medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 18 | $149 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Temple
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Muhammad IrfanTomball$30.6M
- Aung NaingHouston$30.6M
- Robert BassSan Antonio$25.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
- Hernan SalazarSan Antonio$18.5M
- Nicholas ShortHouston$17.6M
- Salma SaigerMesquite$16.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.